IFO50295 NB-1
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | IFO50295 | Cell Name | NB-1 |
---|---|---|---|
Profile | neuroblastoma | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | M | Age | 2 |
Identity | available | Tissue for Primary Cancer | neural |
Case history | neuroblastoma | Metastasis | |
Tissue Metastasized | Genetics | ||
Life Span | infinite | Crisis PDL | |
Morphology | round-neuron-like | Character | neuroblastoma, neuronal differentiation |
Classify | tumor | Established by | Miyake, S. |
Registered by | Suzuki,T. | Regulation for Distribution | |
Comment | Year | 1990 | |
Medium | RPMI1640 medium with 10% fetal bovine serum | Methods for Passages | 0.02% EDTA-PBS |
Cell Number on Passage | Race | ||
CO2 Conc. | 5 % | Tissue Sampling | sympatho-adrenal cell |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:590688 | Radiosensitivity of human neuroblastoma cell line (NB-1). Ohnuma N,Kasuga T,Nojiri I,Furuse T Gan. 1977 Oct;68(5):711-2 |
Pubmed id:201151 | Differentiation of human neuroblastoma cells in vitro--morphological changes induced by dibutyrl cyclic AMP. Ishikawa S Acta Pathol Jpn. 1977 Sep;27(5):697-711 |
Pubmed id:12256 | Acetylcholine synthesis in sympathetic human neuroblastoma. Imashuku S,Inui A,Kusunoki T,Okabe H,Yonezawa T J Pediatr Surg. 1976 Dec;11(6):949-54 |
Pubmed id:174024 | [Morphological differentiation in vitro of human continuous and functional neuroblastoma cell line, NB-I under treatment of (But)2cAMP (author's transl)]. Miyake S,Shimo Y,Kitamura T No Shinkei Geka. 1975 May;3(5):407-14 |
Pubmed id:4144593 | Catecholamine metabolism in tissue culture cells of a neuroblastoma. Imashuku S,Inui A,Nakamura T,Tanaka J,Miyake S J Clin Endocrinol Metab. 1973 May;36(5):931-6 |
Images |
---|
Movies |
---|
LOT Information
Cell No. | IFO50295 | Cell Name | |
---|---|---|---|
LOT No. | 12092005 | Lot Specification | distribution |
Medium | RPMI1640 medium with 10% fetal bovine serum (FBS lot; GIBCO 4218333S) | Temperature | 37 C |
Cell Density at Seeding | 0.6 - 1.4 x 10^4 cells/ml | Methods for Passages | treatment with 0.02% EDTA in Ca, Mg-free PBS |
Doubling Time | approx. 1 day | Cell Number in Vial (cells/1ml) | 7.1 x 10^6 |
Viability at cell freezing (%) | 99 | Antibiotics Used | free |
Passage Number | Unknown (10 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), LD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | D5S818:9,11 D13S317:10,13 D7S820:8,12 D16S539:9 VWA:16,19 TH01:7 AM:X TPOX:11 CSF1PO:10,12 |
|
Adhesion | Exoteric Gene | ||
Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | IFO50295 | Cell Name | NB-1 |
---|---|---|---|
LOT No. | 980 | Lot Specification | distribution |
Medium | RPMI 1640, 90% ; FBS, 10% | Temperature | 37 C |
Cell Density at Seeding | Methods for Passages | 0.02% EDTA-PBS | |
Doubling Time | Cell Number in Vial (cells/1ml) | 5 x 10^6 | |
Viability at cell freezing (%) | 90 | Antibiotics Used | free |
Passage Number | Unknown (10 at IFO) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NP, G6PD(type B), MD |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Exoteric Gene | ||
Medium for Freezing | 10% DMSO, 20% serum (final conc.) - culture medium | CO2 Conc. | |
Viability immediately after thawing (%) | Additional information |
Cell No. | IFO50295 | Cell Name | NB-1 |
---|---|---|---|
LOT No. | 09252019 | Lot Specification | distribution |
Medium | RPMI 1640 medium with 10% fetal bovine serum (FBS; Sigma Cat. # 172012) | Temperature | 37 C |
Cell Density at Seeding | 1 x 10^5 cells/mL | Methods for Passages | treatment with 0.02% EDTA in Ca, Mg-free PBS |
Doubling Time | approx. 32 hrs. | Cell Number in Vial (cells/1ml) | 3.3 x 10^6 |
Viability at cell freezing (%) | approx. 10 | Antibiotics Used | free |
Passage Number | Unknown (9 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - RPMI 1640 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 84.3 | Additional information |